JAK2 mutation status, hemostatic risk factors and thrombophilic factors in essential thrombocythemia (ET) patients

JAK2 mutation status, hemostatic risk factors and thrombophilic factors in essential thrombocythemia (ET) patients

The recently discovered JAK2 V617F point mutation, found in 50–60% of ET patients, has been reported to be associated with a higher risk of thrombotic events. In this study, we explored if JAK2 V617F mutation, or coexisting thrombophilic and hemostatic risk factors, contributed to thes...

Full description

Bibliographic Details
Main Authors: Anna Dmoszyńska, Martyna Kandefer-Szerszeń, Anna M. Kowalska, Tomasz Gromek, Adam Walter-Croneck, Katarzyna Wejksza, Sylwia Chocholska, Ksenia Bykowska, Aleksandra Nowaczyńska, Bożena Sokołowska
Format: Article
Language:English
Published: Via Medica 2011-07-01
Series:Folia Histochemica et Cytobiologica
Subjects:
JAK2 mutation
ET
thrombophilic factors
Online Access:http://czasopisma.viamedica.pl/fhc/article/view/4123

Internet

http://czasopisma.viamedica.pl/fhc/article/view/4123

Similar Items